Taiwan
Senhwa Biosciences Receives FDA Green Light for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors
Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious disea...
August 07, 2024 | News
Taiwan's Global Confluence of Biotech Innovation and Investment: BioAsia Taiwan 2024
BioAsia Taiwan 2024, a paramount event in the global biotech calendar, recently wrapped up a compelling three-day summit, attracting top-tier professionals...
July 29, 2024 | News
Senhwa Biosciences Submits IND to FDA for Phase I/II Trial of Silmitasertib in Pediatric Relapsed Refractory Solid Tumors
Senhwa Biosciences, Inc. (TPEx: 6492), announced IND Submission to US FDA for the Phase I/II study of Silmitasertib (CX-4945) in combination with chemother...
July 15, 2024 | News
Thermo Fisher Scientific Opens First Electron Microscopy Demo Center in Taiwan to Propel Semiconductor Innovation
To support next-generation semiconductor and materials innovation, Thermo Fisher Scientific today announced the opening of its first electron microscopy de...
July 10, 2024 | News
HiRO Acquires DeltaMed Solutions, Expands Across 10 Countries
Harvest Integrated Research Organization (HiRO), a full-service, boutique global CRO, is excited to announce its latest strategic move with the successful ...
July 02, 2024 | News
MLB Receives FDA Approval for TML-6 IND Application to Treat Alzheimer's Disease
MLB (Merry Life Biomedical Company, Ltd., Taiwan ) a biomedical company, announced that the U.S. Food and Drug Administration (FDA) h...
June 07, 2024 | News
Wistron and imedtac Collaborate with CMUH to Promote Advanced Medical Solutions in Malaysia
China Medical University Hospital (CMUH, Taiwan) and the Malaysian International Medical University (IMU), the first and top private medical and heal...
June 03, 2024 | News
Formosa Pharmaceuticals Strikes Exclusive Licensing Deal with Tabuk for Innovative Eye Surgery Drug in MENA
Taiwan-based Formosa Pharmaceuticals announced that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing ...
May 10, 2024 | News
CMUH and Microsoft Azure Introduce "gHi System" for AI-Assisted Medical Documentation
China Medical University Hospital (CMUH) and Microsoft Taiwan announced the Generative Healthcare Intelligent (gHi) System, which is being applied to ...
April 03, 2024 | News
Roche Taiwan Joins Forces with TTY Biopharm, Ushering in a New Dawn for Cancer Care
Roche Taiwan has announced a pioneering partnership with TTY Biopharm Company Limited, aiming to broaden its influence in the fight against cancer in Taiwa...
March 27, 2024 | News
BioGate Announces Breakthrough in Pancreatic Cancer Treatment with New Drug BGX
Under the leadership of Dr. Frank Huang, Chairman and CEO, BioGate disclosed that their in-house research and development team has engineered BGX by integr...
March 07, 2024 | News
Caliway's CBL-514 Gains FDA Orphan Drug and Fast Track Designations for Dercum's Disease Treatment
Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to CBL-514 for Dercum...
March 05, 2024 | News
Synbio Tech's Probiotic TWK10 Earns Taiwan FDA Approval for Anti-fatigue Health Claim
Synbio Tech is thrilled to announce that its groundbreaking probiotic strain, Lactiplantibacillus plantarum TWK10, has been awarded a prestigious...
February 19, 2024 | News
Acepodia Gains FDA Clearance for ACE2016, Initiates Phase 1 Study on Solid Tumor Treatment
This clearance marks a significant milestone for Acepodia, allowing the initiation of a Phase 1, first-in-human clinical trial to assess th...
February 05, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
